ARCHIVES

Chabner Criticizes FDA Crackdown On Off-Label Info

This article is from The Cancer Letter archive.

Vol. 17 No. 26 | June 28, 1991

Download PDF Visit The Full Archive

Related Articles

In Brief: CFO Dwain Morris to Leave MD Anderson Cancer Center

May 2, 2014

Ford Budget Gives NCI Same Amount As FY 1977; Carter Probably Won’t Ask For Any Increase

January 21, 1977

DCT Board Approves Concepts For Acoustic Microscopy, Taxol Development, AIDS R&D

June 15, 1990

Ivax Paclitaxel To Remain On Market In Deal With BMS.

February 1, 2002

Panel Explores Barriers In Access To Cancer Care.

February 2, 2001

FDA Working On New Ground Rules For “Adaptive” Clinical Trial Designs.

July 14, 2006